HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 409 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $15,239,671 | +26.8% | 291,056 | -1.5% | 0.04% | +25.0% |
Q1 2024 | $12,022,583 | +20.7% | 295,541 | +9.7% | 0.03% | -3.0% |
Q4 2023 | $9,961,385 | +3.0% | 269,518 | +6.4% | 0.03% | -29.8% |
Q3 2023 | $9,673,463 | +3.9% | 253,232 | -1.9% | 0.05% | +30.6% |
Q2 2023 | $9,310,425 | -4.6% | 258,121 | +1.0% | 0.04% | +56.5% |
Q1 2023 | $9,760,906 | -33.8% | 255,588 | -1.4% | 0.02% | -75.5% |
Q4 2022 | $14,753,033 | +5467.2% | 259,280 | +3769.9% | 0.09% | +3033.3% |
Q3 2022 | $265,000 | +1.1% | 6,700 | +12.5% | 0.00% | 0.0% |
Q2 2022 | $262,000 | – | 5,953 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |